Completed NA INTERVENTIONAL 2-arm NCT02585986

Intervention Study to Evaluate a Probiotic in Mild Atopic Dermatitis Young Patients

Randomized, Double Blind, Placebo-controlled Intervention Study to Evaluate Safety and Efficiency of a Probiotic in Symptoms Reduction and Use of Topic Corticoids in Mild Atopic Dermatitis Patients Aged 4 to 17 Years

Sponsor: Biopolis S.L.

Conditions Dermatitis, Atopic

Interventions Placebo Probiotic

Updated 5 times since 2017 Last updated: Sep 11, 2016 Started: Jan 31, 2016 Primary completion: Jul 31, 2016 Completion: Aug 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Dermatitis, Atopic, this trial is completed. The trial is conducted by Biopolis S.L. and has accumulated 5 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Biopolis S.L.
Korott, S.L.

Data source: Biopolis S.L.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Alicante, Spain